Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin,…

By daniellenierenberg

Hamadani M. Autologous hematopoietic cell transplantation: an update for clinicians. Ann Med. 2014;46(8):61932.

CAS Article Google Scholar

Singh N, Loren AW. Overview of hematopoietic cell transplantation for the treatment of hematologic malignancies. Clin Chest Med. 2017;38(4):57593.

Article Google Scholar

Hubel K, de la Rubia J, Azar N, Corradini P. Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. Eur J Haematol. 2015;94(1):1222.

Article Google Scholar

Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51(6):78692.

CAS Article Google Scholar

Rao K, Darrington DL, Schumacher JJ, Devetten M, Vose JM, Loberiza FR Jr. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence. Biol Blood Marrow Transplant. 2007;13(12):150814.

Article Google Scholar

Sheets WSAF: The Global Cancer Observatory. International Agency for Research on Cancer 2021.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394424.

Article Google Scholar

Hierlmeier S, Eyrich M, Wolfl M, Schlegel PG, Wiegering V. Early and late complications following hematopoietic stem cell transplantation in pediatric patientsa retrospective analysis over 11 years. PLoS ONE. 2018;13(10): e0204914.

Article Google Scholar

Rahman S, Rybicki L, Ky Hamilton B, Pohlman B, Jagadeesh D, Cober E, Kalaycio M, Dean R, Sobecks R, Mossad SB, et al. Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma. Transplant Infect Dis. 2019;21(4): e13114.

Article Google Scholar

Linke C, Tragiannidis A, Ahlmann M, Frohlich B, Waltermann M, Burkhardt B, Rossig C, Groll AH. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center. Mycoses. 2019;62(10):95460.

Article Google Scholar

Alonso CD, Dufresne SF, Hanna DB, Labbe AC, Treadway SB, Neofytos D, Belanger S, Huff CA, Laverdiere M, Marr KA. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. Biol Blood Marrow Transplant. 2013;19(10):15028.

Article Google Scholar

Signorelli J, Zimmer A, Liewer S, Shostrom VK, Freifeld A. Incidence of febrile neutropenia in autologous hematopoietic stem cell transplant (HSCT) recipients on levofloxacin prophylaxis. Transplant Infect Dis. 2020;22(2): e13225.

Article Google Scholar

Youssef A, Hafez H, Madney Y, Elanany M, Hassanain O, Lehmann LE, El Haddad A. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations. Pediatr Transplant. 2020;24(1): e13610.

Article Google Scholar

Styczynski J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. 2020;55(1):12636.

Article Google Scholar

Esquirol A, Pascual MJ, Kwon M, Perez A, Parody R, Ferra C, Garcia Cadenas I, Herruzo B, Dorado N, Hernani R, et al. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant. 2021;56(10):243244.

CAS Article Google Scholar

Christopeit M, Schmidt-Hieber M, Sprute R, Buchheidt D, Hentrich M, Karthaus M, Penack O, Ruhnke M, Weissinger F, Cornely OA, et al. Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2021;100(2):32136.

CAS Article Google Scholar

Gassas RS, Absi AN, Alghamdi AA, Alsaeed AS, Alamoudi SM, Hemaidi IY, Alahmadi MD, Rajkhan WA, Khalil MM, Dadah SK, et al. Early infection in post-autologous hematopoietic stem cell transplant patients: Princess Noorah Oncology Center experience. Saudi Med J. 2021;42(8):84752.

Article Google Scholar

Danylesko I, Sareli R, Varda-Bloom N, Yerushalmi R, Shem-Tov N, Magen H, Shimoni A, Nagler A. Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation. Int J Hematol. 2021;114(3):36372.

CAS Article Google Scholar

Autore F, Piccirillo N, Nozza A, Innocenti I, Putzulu R, Chiusolo P, Sora F, Zini G, Bacigalupo A, Castagna L, et al. Which is the best mobilizing regimen in POEMS syndrome? A retrospective Italian study of two haematological centres. Blood. 2018;132:5692.

Article Google Scholar

Kumar L, Ramavath D, Kataria B, Tiwari A, Raj A, Chellapuram SK, Mookerjee A, Sahoo RK, Malik PS, Sharma A, et al. High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: predictors of long-term outcome. Indian J Med Res. 2019;149(6):7309.

Article Google Scholar

Colita A, Colita A, Bumbea H, Croitoru A, Orban C, Lipan LE, Craciun OG, Soare D, Ghimici C, Manolache R, et al. LEAM vs. BEAM vs. CLV conditioning regimen for autologous stem cell transplantation in malignant lymphomas. Retrospective comparison of toxicity and efficacy on 222 patients in the first 100 days after transplant, on behalf of the Romanian society for bone marrow transplantation. Front Oncol. 2019;9:892.

Article Google Scholar

Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant. 2002;29(7):54552.

CAS Article Google Scholar

Teltschik HM, Heinzelmann F, Gruhn B, Feuchtinger T, Schlegel P, Schumm M, Kremens B, Mller I, Ebinger M, Schwarze CP, et al. Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients. Br J Haematol. 2016;175(1):11522.

CAS Article Google Scholar

Hof H. IFI = invasive fungal infections. What is that? A misnomer, because a non-invasive fungal infection does not exist! Int J Infecti Dis. 2010;14(6):e458-459.

Article Google Scholar

Styczyski J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. 2020;55(1):12636.

Article Google Scholar

Moghnieh R, Abdallah D, Awad L, Jisr T, Mugharbil A, Youssef A, Tamim H, Khaldieh S, Massri O, Rashini N, et al. Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decades experience from Lebanon. Infection. 2018;46(6):82335.

CAS Article Google Scholar

Srinivasan A, McLaughlin L, Wang C, Srivastava DK, Shook DR, Leung W, Hayden RT. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience. Transpl infectious Dis. 2014;16(1):907.

CAS Article Google Scholar

Jantunen E, Salonen J, Juvonen E, Koivunen E, Siitonen T, Lehtinen T, Kuittinen O, Leppa S, Anttila VJ, Itala M, et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol. 2004;73(3):1748.

CAS Article Google Scholar

McCarthy PL Jr, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, Isola L, Lazarus HM, Lee SJ, Lemaistre CF, et al. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 19952005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. Biol Blood Marrow Transplant. 2013;19(7):111623.

Article Google Scholar

Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Gastineau DA, Litzow MR, Winters JL, Markovic SN. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant. 2008;14(7):80716.

Article Google Scholar

Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef IN, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood. 2001;98(3):57985.

CAS Article Google Scholar

Read the original here:
Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin,...